| scholarly article | Q13442814 |
| P50 | author | Jean-Laurent Casanova | Q17322542 |
| Eamonn R Maher | Q56435841 | ||
| Minji Byun | Q58886111 | ||
| Avinash Abhyankar | Q87628939 | ||
| Sophie Hambleton | Q87744473 | ||
| Anne Puel | Q30503754 | ||
| Laurent Abel | Q30503755 | ||
| Neil V Morgan | Q37383369 | ||
| Frédéric Rieux-Laucat | Q37645087 | ||
| P2093 | author name string | Stefan J Riedl | |
| David McDonald | |||
| Lakshmanane Premkumar | |||
| Andrew Cant | |||
| Alexandre Bolze | |||
| Chris M Bacon | |||
| Ki Pang | |||
| Alison Britland | |||
| P2860 | cites work | Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II | Q22010404 |
| FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis | Q24307362 | ||
| The Fas-FADD death domain complex structure unravels signalling by receptor clustering | Q24312945 | ||
| Exome sequencing identifies the cause of a mendelian disorder | Q24607742 | ||
| Targeted capture and massively parallel sequencing of 12 human exomes | Q24615381 | ||
| Functional hyposplenism | Q68176897 | ||
| Familial asplenia, other malformations, and sudden death | Q71148368 | ||
| Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome | Q74595817 | ||
| The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data | Q27860742 | ||
| The Sequence Alignment/Map format and SAMtools | Q27860966 | ||
| Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency | Q28204372 | ||
| Detection, education and management of the asplenic or hyposplenic patient | Q28207050 | ||
| FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis | Q28265012 | ||
| FADD: a regulator of life and death | Q28286149 | ||
| Fas-associated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of Irf7 | Q28286830 | ||
| FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function | Q28307801 | ||
| Apoptosis: controlled demolition at the cellular level | Q29620114 | ||
| Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity | Q33488225 | ||
| T cell intrinsic roles of autophagy in promoting adaptive immunity | Q33936116 | ||
| Whole exome sequencing and homozygosity mapping identify mutation in the cell polarity protein GPSM2 as the cause of nonsyndromic hearing loss DFNB82. | Q33960515 | ||
| Fas-associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis | Q34059345 | ||
| Isolated congenital asplenia: a French nationwide retrospective survey of 20 cases | Q34138388 | ||
| Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma | Q34243449 | ||
| Primary immunodeficiencies: a field in its infancy | Q34659118 | ||
| A partial form of recessive STAT1 deficiency in humans | Q34980624 | ||
| The CD95(APO-1/Fas) DISC and beyond | Q35091401 | ||
| Primary immunodeficiencies associated with pneumococcal disease | Q35581712 | ||
| A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome. | Q36454970 | ||
| Genetic defects of apoptosis and primary immunodeficiency | Q37142878 | ||
| Death receptor signal transducers: nodes of coordination in immune signaling networks | Q37417486 | ||
| A FADD-dependent innate immune mechanism in mammalian cells | Q38334155 | ||
| Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo | Q40296138 | ||
| Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome | Q55670225 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Fas associated via death domain | Q994646 |
| positive regulation of type I interferon-mediated signaling pathway | Q14907135 | ||
| FADD-related immunodeficiency | Q55784034 | ||
| P304 | page(s) | 873-81 | |
| P577 | publication date | 2010-12-10 | |
| P1433 | published in | American Journal of Human Genetics | Q4744249 |
| P1476 | title | Whole-exome-sequencing-based discovery of human FADD deficiency | |
| P478 | volume | 87 |
| Q37173593 | A Multiplex Kindred with Hennekam Syndrome due to Homozygosity for a CCBE1 Mutation that does not Prevent Protein Expression |
| Q36488254 | A genome-wide perspective of human diversity and its implications in infectious disease |
| Q37624332 | A homozygous PDE6D mutation in Joubert syndrome impairs targeting of farnesylated INPP5E protein to the primary cilium |
| Q21090962 | A mild form of SLC29A3 disorder: a frameshift deletion leads to the paradoxical translation of an otherwise noncoding mRNA splice variant |
| Q34614865 | A novel homozygous p.R1105X mutation of the AP4E1 gene in twins with hereditary spastic paraplegia and mycobacterial disease |
| Q92920530 | A purely quantitative form of partial recessive IFN-γR2 deficiency caused by mutations of the initiation or second codon |
| Q35540935 | Accounting for genetic heterogeneity in homozygosity mapping: application to Mendelian susceptibility to mycobacterial disease |
| Q36162984 | Activity of Uncleaved Caspase-8 Controls Anti-bacterial Immune Defense and TLR-Induced Cytokine Production Independent of Cell Death |
| Q37416405 | An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis |
| Q37183603 | Application of next-generation sequencing in clinical oncology to advance personalized treatment of cancer |
| Q37435858 | Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities. |
| Q47151016 | Autoimmune lymphoproliferative syndrome: more than a FAScinating disease. |
| Q38976987 | Clinical Applications of Next-Generation Sequencing in Cancer Diagnosis |
| Q27024342 | Computational and statistical approaches to analyzing variants identified by exome sequencing |
| Q24318764 | Congenital asplenia in mice and humans with mutations in a Pbx/Nkx2-5/p15 module |
| Q36585185 | Cystic fibrosis testing in a referral laboratory: results and lessons from a six-year period |
| Q35999462 | DNA sequencing: clinical applications of new DNA sequencing technologies. |
| Q30540814 | De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy |
| Q34691675 | Deep sequencing of patient genomes for disease diagnosis: when will it become routine? |
| Q47269331 | Development of envelope protein antigens to serologically differentiate Zika from dengue virus infection |
| Q36019509 | Diagnosis of mitochondrial disorders by concomitant next-generation sequencing of the exome and mitochondrial genome |
| Q27003187 | Discovery of single-gene inborn errors of immunity by next generation sequencing |
| Q26866283 | Disease gene identification strategies for exome sequencing |
| Q38976164 | Exome and genome sequencing for inborn errors of immunity |
| Q38559636 | Exome sequencing a review of new strategies for rare genomic disease research |
| Q34291486 | Exome sequencing and genetic testing for MODY. |
| Q29615382 | Exome sequencing as a tool for Mendelian disease gene discovery |
| Q38175288 | Exome sequencing greatly expedites the progressive research of Mendelian diseases |
| Q45397210 | Exome sequencing identifies novel compound heterozygous mutations of IL-10 receptor 1 in neonatal-onset Crohn's disease |
| Q28731354 | Exome sequencing: a transformative technology |
| Q37634128 | Exome-based mapping and variant prioritization for inherited Mendelian disorders |
| Q90382743 | FADD in Cancer: Mechanisms of Altered Expression and Function, and Clinical Implications |
| Q92072033 | Flow Cytometry Contributions for the Diagnosis and Immunopathological Characterization of Primary Immunodeficiency Diseases With Immune Dysregulation |
| Q35144610 | Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis |
| Q89686779 | Genetic basis for iMCD-TAFRO |
| Q47726876 | Genetic heterogeneity of uncharacterized childhood autoimmune diseases with lymphoproliferation. |
| Q28478905 | Genetic mapping and exome sequencing identify variants associated with five novel diseases |
| Q59794799 | Genomic Interventions in Medicine |
| Q36560000 | Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial disease |
| Q42232915 | HomozygosityMapper2012--bridging the gap between homozygosity mapping and deep sequencing |
| Q35671268 | Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia |
| Q26775894 | Human genetic basis of interindividual variability in the course of infection |
| Q22065433 | Human genome sequencing in health and disease |
| Q28741093 | IL-12Rβ1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and Turkey |
| Q24301912 | Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency |
| Q35190461 | Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kind |
| Q38235840 | Inborn errors of metabolism underlying primary immunodeficiencies |
| Q24306407 | Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunity |
| Q34406086 | Inherited MST1 deficiency underlies susceptibility to EV-HPV infections |
| Q99708569 | Integration of innate immune signaling by caspase-8 cleavage of N4BP1 |
| Q37104059 | Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases |
| Q33917973 | Invasive pneumococcal disease in children can reveal a primary immunodeficiency |
| Q36033806 | Mendelian susceptibility to mycobacterial disease in egyptian children |
| Q53688072 | Microdeletion on chromosome 8p23.1 in a familial form of severe Buruli ulcer. |
| Q37670054 | Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations |
| Q37130222 | New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe. |
| Q24609806 | Newborn screening for SCID identifies patients with ataxia telangiectasia |
| Q38824037 | Newborn screening for SCID: lessons learned |
| Q51485505 | Newborn screening for SCID: three years of experience. |
| Q38267187 | Newborn screening for SCID: where are we now? |
| Q84945150 | Next-generation diagnostics for inherited skin disorders |
| Q38029472 | Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders |
| Q33828771 | Performance of microarray and liquid based capture methods for target enrichment for massively parallel sequencing and SNP discovery |
| Q27001032 | Population genetic tools for dissecting innate immunity in humans |
| Q53086157 | Rare autoimmune disorders with Mendelian inheritance. |
| Q41868170 | Reducing the exome search space for mendelian diseases using genetic linkage analysis of exome genotypes |
| Q39277444 | Restimulation-induced cell death: new medical and research perspectives. |
| Q37844489 | Revisiting Mendelian disorders through exome sequencing |
| Q34338736 | Ribosomal protein SA haploinsufficiency in humans with isolated congenital asplenia |
| Q34163502 | Statistical guidance for experimental design and data analysis of mutation detection in rare monogenic mendelian diseases by exome sequencing |
| Q34091422 | Systematic comparison of three methods for fragmentation of long-range PCR products for next generation sequencing |
| Q57078448 | The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions |
| Q38125937 | The application of next-generation sequencing in the autozygosity mapping of human recessive diseases |
| Q64104128 | The classical NLRP3 inflammasome controls FADD unconventional secretion through microvesicle shedding |
| Q35619447 | The expanding spectrum of the autoimmune lymphoproliferative syndromes |
| Q61053820 | The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses |
| Q37672566 | The next-generation sequencing revolution and its impact on genomics |
| Q37932636 | Unlocking Mendelian disease using exome sequencing |
| Q37021842 | Whole-exome sequencing to analyze population structure, parental inbreeding, and familial linkage |
| Q35567101 | Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants |
| Q35627358 | You never call, you never write: why return of 'omic' results to research participants is both a good idea and a moral imperative |
Search more.